Cargando…

Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis

INTRODUCTION: Glycolysis affects glucose determination in vitro. The placement of sample tubes in ice-water slurry with plasma separation within 30 minutes is recommended, or alternatively the use of a glycolysis inhibitor. The aim of our two-steps study was to evaluate which Terumo tube is best for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonetti, Graziella, Carta, Mariarosa, Montagnana, Martina, Lo Cascio, Claudia, Bonfigli, Anna Rita, Mosca, Andrea, Testa, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783092/
https://www.ncbi.nlm.nih.gov/pubmed/26981020
http://dx.doi.org/10.11613/BM.2016.006
_version_ 1782420070725582848
author Bonetti, Graziella
Carta, Mariarosa
Montagnana, Martina
Lo Cascio, Claudia
Bonfigli, Anna Rita
Mosca, Andrea
Testa, Roberto
author_facet Bonetti, Graziella
Carta, Mariarosa
Montagnana, Martina
Lo Cascio, Claudia
Bonfigli, Anna Rita
Mosca, Andrea
Testa, Roberto
author_sort Bonetti, Graziella
collection PubMed
description INTRODUCTION: Glycolysis affects glucose determination in vitro. The placement of sample tubes in ice-water slurry with plasma separation within 30 minutes is recommended, or alternatively the use of a glycolysis inhibitor. The aim of our two-steps study was to evaluate which Terumo tube is best for glucose determination in routine clinical setting. MATERIALS AND METHODS: In the first study, blood from 100 volunteers was collected into lithium heparin (LH), NaF/Na heparin (FH) and NaF/citrate buffer/Na(2)EDTA (FC-Mixture) tubes. LH sample was treated as recommended and considered as reference, while FH and FC-Mixture samples were aliquoted, maintained at room temperature (RT) for 1, 2 and 4 hours; centrifuged and plasma analysed in triplicate. In the second study, samples from 375 volunteers were collected in LH, FH and FC-Mixture tubes and held at RT before centrifugation from 10 to 340 minutes, depending on each laboratory practice. Samples were analysed in one analytical run. RESULTS: In the first study, FH glucose concentrations were 5.15 ± 0.66 mmol/L, 5.05 ± 0.65 mmol/L and 5.00 ± 0.65 mmol/L (P < 0.001) in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases in all time points exceeded the analytical goal for desirable bias based on biological variation criteria. FC-Mixture glucose concentrations were 5.48 ± 0.65 mmol/L, 5.46 ± 0.6 mmol/L and 5.46 ± 0.64 mmol/L in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases for FC-Mixture glucose in all time points reached optimal analytical goals. In the second study, the biases for LH and FH glucose compared to reference FC-Mixture glucose exceeded the preset analytical goals, regardless of the blood collection to centrifugation time interval. CONCLUSIONS: FC-mixture tubes glucose concentrations were preserved up to 4h storage at RT. We confirmed that NaF alone does not allow immediate glycolysis inhibition in real life pre-centrifugation storage conditions (up to 340 minutes). FC-Mixture should be used exclusively for glucose determination in laboratories unable to implement the recommended blood samples’ treatment.
format Online
Article
Text
id pubmed-4783092
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Croatian Society of Medical Biochemistry and Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-47830922016-03-15 Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis Bonetti, Graziella Carta, Mariarosa Montagnana, Martina Lo Cascio, Claudia Bonfigli, Anna Rita Mosca, Andrea Testa, Roberto Biochem Med (Zagreb) Research Article INTRODUCTION: Glycolysis affects glucose determination in vitro. The placement of sample tubes in ice-water slurry with plasma separation within 30 minutes is recommended, or alternatively the use of a glycolysis inhibitor. The aim of our two-steps study was to evaluate which Terumo tube is best for glucose determination in routine clinical setting. MATERIALS AND METHODS: In the first study, blood from 100 volunteers was collected into lithium heparin (LH), NaF/Na heparin (FH) and NaF/citrate buffer/Na(2)EDTA (FC-Mixture) tubes. LH sample was treated as recommended and considered as reference, while FH and FC-Mixture samples were aliquoted, maintained at room temperature (RT) for 1, 2 and 4 hours; centrifuged and plasma analysed in triplicate. In the second study, samples from 375 volunteers were collected in LH, FH and FC-Mixture tubes and held at RT before centrifugation from 10 to 340 minutes, depending on each laboratory practice. Samples were analysed in one analytical run. RESULTS: In the first study, FH glucose concentrations were 5.15 ± 0.66 mmol/L, 5.05 ± 0.65 mmol/L and 5.00 ± 0.65 mmol/L (P < 0.001) in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases in all time points exceeded the analytical goal for desirable bias based on biological variation criteria. FC-Mixture glucose concentrations were 5.48 ± 0.65 mmol/L, 5.46 ± 0.6 mmol/L and 5.46 ± 0.64 mmol/L in tubes stored at RT for 1, 2 and 4 hours, respectively. Mean biases for FC-Mixture glucose in all time points reached optimal analytical goals. In the second study, the biases for LH and FH glucose compared to reference FC-Mixture glucose exceeded the preset analytical goals, regardless of the blood collection to centrifugation time interval. CONCLUSIONS: FC-mixture tubes glucose concentrations were preserved up to 4h storage at RT. We confirmed that NaF alone does not allow immediate glycolysis inhibition in real life pre-centrifugation storage conditions (up to 340 minutes). FC-Mixture should be used exclusively for glucose determination in laboratories unable to implement the recommended blood samples’ treatment. Croatian Society of Medical Biochemistry and Laboratory Medicine 2016-02-15 2016-02-15 /pmc/articles/PMC4783092/ /pubmed/26981020 http://dx.doi.org/10.11613/BM.2016.006 Text en
spellingShingle Research Article
Bonetti, Graziella
Carta, Mariarosa
Montagnana, Martina
Lo Cascio, Claudia
Bonfigli, Anna Rita
Mosca, Andrea
Testa, Roberto
Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
title Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
title_full Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
title_fullStr Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
title_full_unstemmed Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
title_short Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis
title_sort effectiveness of citrate buffer-fluoride mixture in terumo tubes as an inhibitor of in vitro glycolysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783092/
https://www.ncbi.nlm.nih.gov/pubmed/26981020
http://dx.doi.org/10.11613/BM.2016.006
work_keys_str_mv AT bonettigraziella effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT cartamariarosa effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT montagnanamartina effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT locascioclaudia effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT bonfigliannarita effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT moscaandrea effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT testaroberto effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis
AT effectivenessofcitratebufferfluoridemixtureinterumotubesasaninhibitorofinvitroglycolysis